LEFLOTEC

It is indicated for the treatment of adults with mild, moderate, and severe infections caused by susceptible strains of the designated micro-organisms in the conditions listed below:

• Acute bacterial sinusitis.
• Acute bacterial exacerbation of chronic bronchitis.
• Community acquired pneumonia and nosocomial pneumonia.
• Complicated skin and skin structure infections.
• Uncomplicated skin and skin structure infections (mild to moderate) including abscesses, cellulitis, furuncles, impetigo, pyoderma, wound infections.
• Chronic bacterial prostatitis.
• Complicated urinary tract infections (mild to moderate).
• Uncomplicated urinary tract infections (mild to moderate).
• Acute pyelonephritis (mild to moderate).
• Inhalational anthrax, post-exposure.